大脑干体体积的减少作为阿尔茨海默病风险人群的关键宏观结构指标
Thomas M Lancaster1,2, Kevin Murphy3, Hannah Chandler3
1Cardiff University Brain Research Imaging Centre (CUBRIC), School of Physics and Astronomy, Cardiff University, Maindy Road, Cathays, Cardiff, CF24 4HQ, UK. tml45@bath.ac.uk.
Alzheimer's research & therapy
|July 27, 2025
概括
大脑干体积的减少是阿尔茨海默病 (AD) 风险的早期指标,在其他大脑变化之前出现. 这一发现突出了大脑干作为临床前阿尔茨海默病和自主功能障碍的潜在生物标志物.
科学领域:
- 神经成像是一种神经成像.
- 神经退行发生神经退行.
- 生物标志物发现发现
背景情况:
- 阿尔茨海默氏病 (AD) 与大脑的宏观结构变化有关,特别是在带状和中间叶.
- 大脑干在自主功能中的作用及其作为临床前阿尔茨海默病早期生物标志物的潜力尚未得到充分探索.
研究的目的:
- 为了研究脑干体体积作为阿尔茨海默病 (AD) 风险的早期标志物.
- 评估大脑干体体积与临床前AD指标 (如轻度认知障碍 (MCI) 和多基因风险评分) 之间的关联.
主要方法:
- 用多个线性回归来分析患有阿尔茨海默病 (MCI或高多原风险) 风险的无症状个体的大脑干体体积.
- 对脑干体体积和150个其他结构MRI特征之间的关联进行了比较.
- 使用英国生物银行数据集进行复制分析.
主要成果:
- 在MCI和高多基因风险组中观察到脑干体积减少.
- 临床前阿尔茨海默病标志物和脑干体积之间的关联比其他150个MRI特征更强.
- 在英国生物库的复制证实了AD多基因风险得分与大脑干体体积减少之间的关联.
结论:
- 减少脑干体积是阿尔茨海默病风险的早期指标,在其他形态变化之前.
- 大脑干可能是AD中神经退行症的初始部位,将自主功能障碍与AD风险联系起来.
- 大脑干需要进一步研究,作为潜在的生物标志物和AD预防的治疗点.
相关概念视频
Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Alzheimer Disease l: Introduction
21
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
21
Alzheimer Disease ll: Pathophysiology
35
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
35
Dementia l: Introduction
35
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
35


